Moderna, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Moderna, Inc. (MRNA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are MRNA insiders buying or selling?
In the last 12 months, Moderna, Inc. insiders reported 0 open-market purchases ($0) and 15 sales ($81.6M) — net selling of $81.6M. Since September 2019, Trabud has recorded 826 Form 4 filings for MRNA: 3 buys ($7.0M) and 823 sells ($3.8B).
Source: SEC EDGAR Form 4
What stands out
- No Moderna, Inc. insider made an open-market purchase in the last 12 months; the 15 reported open-market sales totaled $81.6M.
Key Statistics (September 2019 – Oct 16, 2026)
Total Form 4 filings
826
SEC EDGAR
Insider filers
19
Insider buys (3)
$7.0M
Insider sells (823)
$3.8B
Insider sentiment
Net sellingNet insider flow of $3.8B in net selling since September 2019, and $81.6M in net selling over the last 12 months.
Recent MRNA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | Stephen Hoge | President | Sale | 78.4K | $217.10 | $17.0M | SEC ↗ |
| Sep 16, 2026 | Stephen Hoge | President | Sale | 80.6K | $145.10 | $11.7M | SEC ↗ |
| Sep 14, 2026 | James M Mock | Chief Financial Officer | Sale | 34.8K | $134.49 | $4.7M | SEC ↗ |
| Sep 3, 2026 | Shannon Thyme Klinger | Chief Legal Officer | Sale | 3.5K | $139.95 | $485.8K | SEC ↗ |
| Aug 7, 2026 | Stephane Bancel | Chief Executive Officer | Sale | 499.2K | $57.52 | $28.7M | SEC ↗ |
| Jul 16, 2026 | Stephen Hoge | President | Sale | 53.3K | $67.60 | $3.6M | SEC ↗ |
| Jun 17, 2026 | Stephen Hoge | President | Sale | 53.3K | $51.37 | $2.7M | SEC ↗ |
| Jun 8, 2026 | Shannon Thyme Klinger | Chief Legal Officer | Sale | 3.5K | $50.00 | $173.6K | SEC ↗ |
| May 22, 2026 | Noubar Afeyan | Director | Sale | 9.3K | $46.84 | $433.9K | SEC ↗ |
| May 18, 2026 | Stephen Hoge | President | Sale | 53.3K | $48.40 | $2.6M | SEC ↗ |
| May 4, 2026 | Abbas Hussain | Director | Sale | 5.7K | $46.63 | $265.0K | SEC ↗ |
| Mar 3, 2026 | Shannon Thyme Klinger | Chief Legal Officer | Sale | 13.9K | $52.29 | $726.0K | SEC ↗ |
| Feb 25, 2026 | Stephen Hoge | President | Sale | 160.0K | $48.84 | $7.8M | SEC ↗ |
| Dec 15, 2025 | Noubar Afeyan | Director | Sale | 23.9K | $29.49 | $703.3K | SEC ↗ |
| Dec 11, 2025 | Abbas Hussain | Director | Sale | 504 | $27.60 | $13.9K | SEC ↗ |
| Jun 12, 2025 | Abbas Hussain | Director | Sale | 312 | $28.00 | $8.7K | SEC ↗ |
| Mar 4, 2025 | Stephane Bancel | Chief Executive Officer | Purchase | 160.3K | $31.22 | $5.0M | SEC ↗ |
| Mar 4, 2025 | Paul Sagan | Director | Purchase | 31.6K | $31.76 | $1.0M | SEC ↗ |
| Dec 10, 2024 | Shannon Thyme Klinger | Chief Legal Officer | Sale | 529 | $44.68 | $23.6K | SEC ↗ |
| Dec 4, 2024 | Shannon Thyme Klinger | Chief Legal Officer | Sale | 112 | $43.30 | $4.8K | SEC ↗ |
| Dec 4, 2024 | Stephen Hoge | President | Sale | 314 | $43.30 | $13.6K | SEC ↗ |
| Dec 2, 2024 | James M Mock | Chief Financial Officer | Sale | 1.4K | $42.79 | $60.8K | SEC ↗ |
| Dec 2, 2024 | Shannon Thyme Klinger | Chief Legal Officer | Sale | 1.4K | $42.79 | $60.7K | SEC ↗ |
| Dec 2, 2024 | Stephen Hoge | President | Sale | 291 | $42.79 | $12.5K | SEC ↗ |
| Nov 12, 2024 | Stephen Hoge | President | Sale | 277 | $46.10 | $12.8K | SEC ↗ |
Showing the 25 most recent of 826 Form 4 filings for Moderna, Inc..
Most active MRNA insiders
- Stephane Bancel267 filings
- Stephen Hoge147 filings
- Juan Andres145 filings
- Noubar Afeyan86 filings
- Tal Zvi Zaks73 filings
Ask anything about MRNA insider activity
Use Trabud's AI agent to query Moderna, Inc.'s Form 4 history in plain English — "Show me MRNA CEO purchases this year" or compare it against any other ticker.
Open the AI agentMRNA insider trading FAQ
Are Moderna, Inc. insiders buying or selling?
In the last 12 months, Moderna, Inc. insiders reported 0 open-market purchases ($0) and 15 sales ($81.6M) — net selling of $81.6M. Since September 2019, Trabud has recorded 826 Form 4 filings for MRNA: 3 buys ($7.0M) and 823 sells ($3.8B). Over the full record that is net selling of $3.8B.
How many insiders trade MRNA stock?
19 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Moderna, Inc.. The most recent filing was accepted on Oct 16, 2026.
Where does Trabud get MRNA insider trading data?
All MRNA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.